Patients with rheumatoid arthritis (RA) have a greater risk of developing both Hodgkin
lymphoma (HL) and non‐HL than the general population. Non‐Hodgkin lymphoma is more …

Objective The risk of lymphoma is increased in patients with rheumatoid arthritis (RA), and
spontaneous reporting suggests that methotrexate (MTX) and anti–tumor necrosis factor …

To our knowledge, this review is the most broad and only systematic survey to date of the
rheumatology, oncology, and epidemiology literature to determine the prevalence of …

Although long-term clinical studies have shown no excessive risk of lymphomain rheumatoid
arthritis (RA) patients treated with methotrexate (MTX), an increasing number of reports of …

Despite its name, rheumatoid arthritis (RA) is much more than a joint disease. Extraarticular
manifestations may occur in almost any organ system, with nodule formation, interstitial lung …

Objective Patients with rheumatoid arthritis (RA) are at increased risk of malignant
lymphomas with a strong correlation with RA disease severity. Given the changes in RA …

Rheumatologists need to be aware of the increased lymphoma risk in their RA patients. The
reason for the increased lymphoma risk in RA patients is still unclear, but available studies …

Background: Patients with rheumatoid arthritis (RA) are at increased risk of malignant
lymphomas, and maybe also of leukaemia and multiple myeloma. The effect of tumour …

An increasing number of instances of lymphoma in patients with rheumatoid arthritis who are
treated with methotrexate continue to appear. The majority of patients with …

Objective Patients with rheumatoid arthritis (RA) are at increased risk for malignant
lymphomas. Both conditions display a familial aggregation, and there are reports of RA and …